Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...

The business-software group claimed the top spot as Europe’s largest company by market value, dethroning Wegovy maker Novo Nordisk.

Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese ...

The pandemic ushered in a new way of working remotely, but even companies that initially championed the model are changing ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

In conversations with US officials, the pharmaceutical industry argued that tariffs on the EU would increase drug costs and create access barriers for patients ...

Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...

— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...